OPTINOSE INC. - COMMO

Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference

22 نوفمبر 2023 09:00:00 بحسب Nasdaq GlobeNewswire

Optinose Reports Third Quarter 2023 Financial Results and Operational Updates

09 نوفمبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Optinose Announces Reporting Date for Third Quarter 2023 Financial Results

27 أكتوبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Optinose to Present at the 2023 Cantor Global Healthcare Conference

22 سبتمبر 2023 09:01:00 بحسب Nasdaq GlobeNewswire

Optinose Reports Second Quarter 2023 Financial Results and Operational Updates

10 أغسطس 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 Million

27 يوليو 2023 07:00:01 بحسب Nasdaq GlobeNewswire

Optinose Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

16 يونيو 2023 16:08:00 بحسب Nasdaq GlobeNewswire

Optinose to Present at the Jefferies Healthcare Conference

02 يونيو 2023 13:00:00 بحسب Nasdaq GlobeNewswire

Optinose Reports First Quarter 2023 Financial Results and Operational Updates

11 مايو 2023 07:00:18 بحسب Nasdaq GlobeNewswire

Optinose Announces FDA Acceptance of Supplemental New Drug Application for XHANCE

04 مايو 2023 07:00:01 بحسب Nasdaq GlobeNewswire

Optinose Announces Reporting Date for First Quarter 2023 Financial Results

01 مايو 2023 16:30:00 بحسب Nasdaq GlobeNewswire

Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

18 أبريل 2023 08:00:01 بحسب Nasdaq GlobeNewswire

Optinose to Present at the Needham Virtual Healthcare Conference

12 أبريل 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Optinose Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Highlights

07 مارس 2023 07:00:56 بحسب Nasdaq GlobeNewswire

Optinose Announces Reporting Date for Fourth Quarter 2022 Financial Results

28 فبراير 2023 16:30:00 بحسب Nasdaq GlobeNewswire

Optinose Submits Supplemental New Drug Application for XHANCE Label Expansion

21 فبراير 2023 07:00:01 بحسب Nasdaq GlobeNewswire

Optinose Announces CEO Transition and Business Update

31 يناير 2023 07:00:01 بحسب Nasdaq GlobeNewswire

Optinose Appoints Paul Spence as Chief Commercial Officer

15 ديسمبر 2022 16:30:00 بحسب Nasdaq GlobeNewswire

Optinose Announces Departure of Acting Chief Financial Officer

09 ديسمبر 2022 08:00:00 بحسب Nasdaq GlobeNewswire

Optinose Announces Corporate Updates and Presentation at the 34th Annual Piper Sandler Healthcare Conference

30 نوفمبر 2022 07:00:00 بحسب Nasdaq GlobeNewswire